Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Tax Provisions: 2009-2024

Historic Tax Provisions for Myriad Genetics (MYGN) over the last 16 years, with Dec 2024 value amounting to $3.8 million.

  • Myriad Genetics' Tax Provisions rose 33.33% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.8 million, marking a year-over-year decrease of 4033.33%. This contributed to the annual value of $3.8 million for FY2024, which is 245.45% up from last year.
  • Per Myriad Genetics' latest filing, its Tax Provisions stood at $3.8 million for FY2024, which was up 245.45% from $1.1 million recorded in FY2023.
  • Myriad Genetics' Tax Provisions' 5-year high stood at $3.8 million during FY2024, with a 5-year trough of -$59.9 million in FY2020.
  • For the 3-year period, Myriad Genetics' Tax Provisions averaged around -$7.9 million, with its median value being $1.1 million (2023).
  • Per our database at Business Quant, Myriad Genetics' Tax Provisions tumbled by 438.64% in 2020 and then skyrocketed by 245.45% in 2024.
  • Yearly analysis of 5 years shows Myriad Genetics' Tax Provisions stood at -$23.7 million in 2020, then reached -$59.9 million in 2020, then soared by 50.08% to -$29.9 million in 2021, then rose by 4.35% to -$28.6 million in 2022, then skyrocketed by 103.85% to $1.1 million in 2023, then spiked by 245.45% to $3.8 million in 2024.